bioMerieux SAbioMerieux SAbioMerieux SA

bioMerieux SA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪13.94 B‬EUR
3.66EUR
‪432.20 M‬EUR
‪3.98 B‬EUR
‪41.28 M‬
Beta (1Y)
0.53
Employees (FY)
‪14.75 K‬
Change (1Y)
+103 +0.70%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About bioMerieux SA


CEO
Pierre Boulud
Headquarters
Marcy l'Etoile
Founded
1967
ISIN
FR0013280286
FIGI
BBG000QCJG62
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.

Check out other big names from the same industry as EYWN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BIMAB
bioMerieux SA 1.5% 29-JUN-2027
Yield to maturity
Maturity date
Jun 29, 2027
BIMAC
bioMerieux SA 1.902% 29-JUN-2030
Yield to maturity
Maturity date
Jun 29, 2030

See all EYWN bonds 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange bioMerieux SA stocks are traded under the ticker EYWN.
We've gathered analysts' opinions on bioMerieux SA future price: according to them, EYWN price has a max estimate of 140.00 EUR and a min estimate of 118.00 EUR. Watch EYWN chart and read a more detailed bioMerieux SA stock forecast: see what analysts think of bioMerieux SA and suggest that you do with its stocks.
EYWN reached its all-time high on Oct 12, 2020 with the price of 144.40 EUR, and its all-time low was 52.90 EUR and was reached on Jan 3, 2019. View more price dynamics on EYWN chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track bioMerieux SA financials in yearly and quarterly reports right on TradingView.
bioMerieux SA is going to release the next earnings report on Sep 4, 2025. Keep track of upcoming events with our Earnings Calendar.
EYWN net income for the last half-year is ‪216.90 M‬ EUR, while the previous report showed ‪215.30 M‬ EUR of net income which accounts for 0.74% change. Track more bioMerieux SA financial stats to get the full picture.
Yes, EYWN dividends are paid annually. The last dividend per share was 0.90 EUR. As of today, Dividend Yield (TTM)% is 0.78%. Tracking bioMerieux SA dividends might help you take more informed decisions.
bioMerieux SA dividend yield was 0.87% in 2024, and payout ratio reached 24.56%. The year before the numbers were 0.84% and 28.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 4, 2025, the company has ‪14.75 K‬ employees. See our rating of the largest employees — is bioMerieux SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. bioMerieux SA EBITDA is ‪893.30 M‬ EUR, and current EBITDA margin is 22.45%. See more stats in bioMerieux SA financial statements.
Like other stocks, EYWN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade bioMerieux SA stock right from TradingView charts — choose your broker and connect to your account.